Rosuvastatin Completed Phase 4 Trials for Ischemia Reperfusion Injury / Endothelial Dysfunction Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00457652Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
NCT00987974Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury